🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Qun Jiang

The First People's Hospital of Xiaoshan District, Hangzhou

ORCID: 0000-0003-1611-2595

Also affiliated with Yangzhou University

Immunology and MicrobiologyMedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression”.

Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.012

N/A

0.637DataRank · unranked

69 citations

Manakamana Khanal, Junko Murai, Jingli Zhang, Manjistha Sengupta, Qun Jiang +13 more

Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti–PD-1 antibody in patients with mesothelioma and mouse tumor models

Science Translational Medicine(2020)10.1126/scitranslmed.aaz7252

N/A

0.571DataRank · unranked

44 citations

Azam Ghafoor, Idrees Mian, Daniel Rathkey, Anish Thomas, Christine Alewine +8 more

Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.100938

N/A

0.500DataRank · unranked

27 citations

Qun Jiang, Jun S. Wei, Vikram Misra, Betsy Morrow, Chimene Kesserwan +11 more

EpiAgent: foundation model for single-cell epigenomics

Nature Methods(2025)10.1038/s41592-025-02822-z

N/A

0.449DataRank · unranked

19 citations

Keyi Li, Xuejian Cui, Zian Wang, Qun Jiang, Jiacheng Lin +5 more

Transcriptomics based prediction of survival and response to therapy in malignant mesothelioma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.13.488207

N/A

0DataRank · unranked

1 citations

Qun Jiang, Jun S. Wei, Vikram Misra, Betsy Morrow, Chimene Kesserwan +10 more

Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0073

N/A

0DataRank · unranked

46 citations

Jingli Zhang, Manakamana Khanal, Jessica Hong, Abhilash Venugopalan, Qun Jiang +7 more

NAV‐003, a bispecific antibody targeting a unique mesothelin epitope and CD3ε with improved cytotoxicity against humoral immunosuppressed tumors

European Journal of Immunology(2023)10.1002/eji.202250309

N/A

0DataRank · unranked

5 citations

Qun Jiang, Raffit Hassan, Nicholas C. Nicolaides, J. Bradford Kline, Luigi Grasso

Persistence of activated anti‐mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas

Clinical and Translational Medicine(2024)10.1002/ctm2.70057

N/A

0DataRank · unranked

7 citations

Abhilash Venugopalan, Jingli Zhang, Nishanth Ulhas Nair, Manjistha Sengupta, Manakamana Khanal +4 more